Association between genotypes of \(\textit{TLR4}\) gene rs2149356 polymorphism and serum level of il-6 in Vietnamese patients with gout
Authors
DOI: https://doi.org/10.15625/2615-9023/15727Keywords:
Cytokine, ELISA, gout, DNA sequencing, TLR4References
Aderem A. & Ulevitch R. J., 2000. Toll-like receptors in the induction of the innate immune response. Nature, 406: 782−787.
Cavalcanti N. G., Marques C. D., Lins E. L. T. U., Pereira M. C., Rego M. J., Duarte A. L., Pitta Ida R. & Pitta M. G., 2016. Cytokine Profile in Gout: Inflammation Driven by IL-6 and IL-18? Immunol Invest, 45: 383−395.
Crisan T. O., Cleophas M. C., Oosting M., Lemmers H., Toenhake-Dijkstra H., Netea M. G., Jansen T. L. & Joosten L. A., 2016. Soluble uric acid primes TLR-induced proinflammatory cytokine production by human primary cells via inhibition of IL-1Ra. Ann Rheum Dis, 75: 755−762.
Flynn T. J., Phipps-Green A., Hollis-Moffatt J. E., Merriman M. E., Topless R., Montgomery G., Chapman B., Stamp L. K., Dalbeth N. & Merriman T. R., 2013. Association analysis of the SLC22A11 (organic anion transporter 4) and SLC22A12 (urate transporter 1) urate transporter locus with gout in New Zealand case-control sample sets reveals multiple ancestral-specific effects. Arthritis research & therapy, 15: 1−11.
Hollingsworth J. W., Whitehead G. S., Lin K. L., Nakano H., Gunn M. D., Schwartz D. A. & Cook D.N., 2006. TLR4 signaling attenuates ongoing allergic inflammation. J Immunol, 176: 5856−5862.
Hurba O., Mancikova A., Krylov V., Pavlikova M., Pavelka K. & Stiburkova B., 2014. Complex analysis of urate transporters SLC2A9, SLC22A12 and functional characterization of non-synonymous allelic variants of GLUT9 in the Czech population: no evidence of effect on hyperuricemia and gout. PloS one, 9: 1−10.
Itahana Y., Han R., Barbier S., Lei Z., Rozen S. & Itahana K., 2015. The uric acid transporter SLC2A9 is a direct target gene of the tumor suppressor p53 contributing to antioxidant defense. Oncogene, 34: 1799−1810.
Kawamura Y., Matsuo H., Chiba T., Nagamori S., Nakayama A., Inoue H., Utsumi Y., Oda T., Nishiyama J., Kanai Y. & Shinomiya N., 2011. Pathogenic GLUT9 mutations causing renal hypouricemia type 2 (RHUC2). Nucleosides, Nucleotides & Nucleic Acids, 30: 1105−1111.
Kilding R., Akil M., Till S., Amos R., Winfield J., Iles M. M. & Wilson A. G., 2003. A biologically important single nucleotide polymorphism within the toll-like receptor-4 gene is not associated with rheumatoid arthritis. Clin Exp Rheumatol, 21: 340−342.
Li C., Chu N., Wang B., Wang J., Luan J., Han L., Meng D., Wang Y., Suo P., Cheng L., Ma X., Miao Z. & Liu S., 2012. Polymorphisms in the presumptive promoter region of the SLC2A9 gene are associated with gout in a Chinese male population. PloS one, 7: 1−9.
Liu-Bryan R., Scott P., Sydlaske A., Rose D. M. & Terkeltaub R., 2005. Innate immunity conferred by Toll-like receptors 2 and 4 and myeloid differentiation factor 88 expression is pivotal to monosodium urate monohydrate crystal-induced inflammation. Arthritis Rheum, 52: 2936−2946.
Manicassamy S. & Pulendran B., 2009. Modulation of adaptive immunity with Toll-like receptors. Semin Immunol, 21: 185−193.
Martinon F., Petrilli V., Mayor A., Tardivel A. & Tschopp J., 2006. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature, 440: 237−241.
Nguyen H. H., Nguyen T. H., Vu C. D., Nguyen K. T., Le B. V., Nguyen T. L. & Nong V. H., 2012. Novel homozygous p.Y395X mutation in the CYP11B1 gene found in a Vietnamese patient with 11beta-hydroxylase deficiency. Gene, 509: 295−297.
Qing Y. F., Zhou J. G., Zhang Q. B., Wang D. S., Li M., Yang Q. B., Huang C. P., Yin L., Pan S. Y., Xie W. G., Zhang M. Y., Pu M. J. & Zeng M., 2013. Association of TLR4 Gene rs2149356 polymorphism with primary gouty arthritis in a case-control study. PLoS One, 8: 1–9.
Rasheed H., McKinney C., Stamp L.K., Dalbeth N., Topless R. K., Day R., Kannangara D., Williams K., Smith M., Janssen M., Jansen T. L., Joosten L. A., Radstake T. R., Riches P. L., Tausche A. K., Liote F., Lu L., Stahl E. A., Choi H .K., So A. & Merriman T. R., 2016. The Toll-Like Receptor 4 (TLR4) Variant rs2149356 and Risk of Gout in European and Polynesian Sample Sets. PLoS One, 11: 1−8.
VanItallie T. B., 2010. Gout: epitome of painful arthritis. Metabolism, 59 Suppl 1: 32−36.
Downloads
Metrics
Downloads
PDF Downloaded: 90